Healthcare provider profile · identity verified

Lynette M Cugino, MD

Internal Medicine · NORTH CANTON, OH · NPI 1043287501

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	544	134
Levothyroxine Sodium	Levothyroxine Sodium	484	108
Losartan Potassium	Losartan Potassium	375	93
Omeprazole	Omeprazole	320	89
Rosuvastatin Calcium	Rosuvastatin Calcium	310	88
Amlodipine Besylate	Amlodipine Besylate	305	89
Metoprolol Succinate	Metoprolol Succinate	286	76
Pantoprazole Sodium	Pantoprazole Sodium	254	73
Lisinopril	Lisinopril	238	70
Gabapentin	Gabapentin	226	57
Hydrochlorothiazide	Hydrochlorothiazide	165	48
Metformin Hcl Er	Metformin Hcl	154	45
Meloxicam	Meloxicam	138	49
Duloxetine Hcl	Duloxetine Hcl	135	27
Metoprolol Tartrate	Metoprolol Tartrate	130	32
Furosemide	Furosemide	128	40
Sertraline Hcl	Sertraline Hcl	126	34
Fluticasone Propionate	Fluticasone Propionate	122	45
Simvastatin	Simvastatin	116	28
Metformin Hcl	Metformin Hcl	113	33
Escitalopram Oxalate	Escitalopram Oxalate	111	29
Alprazolam	Alprazolam	110	31
Pravastatin Sodium	Pravastatin Sodium	110	29
Tamsulosin Hcl	Tamsulosin Hcl	103	28
Eliquis	Apixaban	102	17
Albuterol Sulfate Hfa	Albuterol Sulfate	101	41
Prednisone	Prednisone	101	75
Trazodone Hcl	Trazodone Hcl	99	28
Potassium Chloride	Potassium Chloride	97	21
Montelukast Sodium	Montelukast Sodium	96	24
Tramadol Hcl	Tramadol Hcl	92	18
Mirtazapine	Mirtazapine	90	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	84	22
Jardiance	Empagliflozin	76	17
Synthroid	Levothyroxine Sodium	74	19
Ozempic	Semaglutide	71	suppressed
Clopidogrel	Clopidogrel Bisulfate	70	23
Carvedilol	Carvedilol	69	15
Glimepiride	Glimepiride	68	16
Cephalexin	Cephalexin	65	48
Allopurinol	Allopurinol	57	15
Memantine Hcl	Memantine Hcl	54	14
Venlafaxine Hcl Er	Venlafaxine Hcl	54	14
Celecoxib	Celecoxib	51	13
Ezetimibe	Ezetimibe	51	11
Azithromycin	Azithromycin	48	42
Oxybutynin Chloride Er	Oxybutynin Chloride	46	12
Pregabalin	Pregabalin	44	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	43	37
Esomeprazole Magnesium	Esomeprazole Magnesium	41	suppressed
Xarelto	Rivaroxaban	41	suppressed
Amoxicillin	Amoxicillin	39	32
Atenolol	Atenolol	39	11
Buspirone Hcl	Buspirone Hcl	39	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	13
Fluoxetine Hcl	Fluoxetine Hcl	38	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	37	suppressed
Diclofenac Sodium	Diclofenac Sodium	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	34	suppressed
Glipizide Er	Glipizide	34	suppressed
Trulicity	Dulaglutide	34	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	13
Methylprednisolone	Methylprednisolone	28	24
Spironolactone	Spironolactone	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Bumetanide	Bumetanide	27	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	24
Benazepril Hcl	Benazepril Hcl	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	18
Nabumetone	Nabumetone	23	12
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Clonazepam	Clonazepam	22	suppressed
Mupirocin	Mupirocin	22	20
Topiramate	Topiramate	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Ketoconazole	Ketoconazole	20	11
Colestipol Hcl	Colestipol Hcl	19	suppressed
Nystatin	Nystatin	19	11
Ondansetron Hcl	Ondansetron Hcl	19	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Valsartan	Valsartan	17	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Cefdinir	Cefdinir	15	12
Enalapril Maleate	Enalapril Maleate	15	suppressed
Famotidine	Famotidine	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Niacin Er	Niacin	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Trimethoprim	Trimethoprim	13	suppressed
Finasteride	Finasteride	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Glipizide	Glipizide	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error